Galectin Therapeutics GALT
NASDAQ GALT
$3.29 -0.09 (-2.66%)
At close: Nov 11, 2026 · 4:00 PM EST

Galectin Therapeutics (GALT) Asset Writedowns and Impairment (2009 - 2014)

Updated

Galectin Therapeutics (GALT) posted Asset Writedowns and Impairment of $15,000 for FY2010.

Analysis

Galectin Therapeutics (GALT) Asset Writedowns and Impairment (2009 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Galectin Therapeutics 224.13 Mn 167.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 351,000.00
Mar 31, 2013 351,000.00
Mar 31, 2012 351,000.00
Mar 31, 2011 351,000.00
Dec 31, 2010 -321,000.00
Mar 31, 2010 336,000.00
Dec 31, 2009 -26,000.00
Mar 31, 2009 181,000.00
API Access

Galectin Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=GALT&period=max&api_key=YOUR_API_KEY